Last reviewed · How we verify

NCT04618055

Clinical Evaluation of NiTiDent Tuah Porous NiTi Dental Implants

Status unknown NA Last updated 7 April 2022
What this trial tests

NA trial testing NiTiDent Tuah Porous NiTi Dental Implants in Partial-edentulism in 105 participants. Status unknown.

Timeline
15 October 2021
Primary endpoint
15 September 2022
15 April 2023

Quick facts

Lead sponsorNitium Technology Sdn Bhd
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment105
Start date15 October 2021
Primary completion15 September 2022
Estimated completion15 April 2023
Sites3 locations across Malaysia

Drugs / interventions tested

Conditions studied

Sponsor

Nitium Technology Sdn Bhd

Who can join

18 and older, any sex, with Partial-edentulism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this prospective, open-label, randomized, double arm multicenter study is to evaluate the safety and clinical performance of a newly developed NiTiDent Tuah porous NiTi dental implant (from Nitium Technology Sdn Bhd) in singletooth gap in the posterior mandible 1 year after implant placement and 8 months after implant loading. Second, To investigate the clinical outcome of the interventional dental implant (NiTiDent Tuah Porous NiTi dental implant) compared to control dental implant. The hypothesis is set to no difference in the clinical outcome for the two types of implants based on the outcomes of the primary and secondary endpoints.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Partial-edentulism

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04618055.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing